NBTY’s Ester-C Plans Under Wraps, But Competitors Respond With Branded Products
This article was originally published in The Pink Sheet Daily
Executive Summary
Stakeholders say they are responding to NBTY not selling Ester-C as an ingredient, and to its apparent plans for exclusivity, creation of mass market brand.
You may also be interested in...
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
FDA Tackles Observational Studies In Draft Health Claims Guidance
"Scientific conclusions from observational studies cannot be drawn about a relationship between a food component and a disease," FDA concludes in draft guidance for health claim petitioners
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: